Due to their large anti-Stokes shifts, sharp emission spectra and long excited-state lifetimes, upconversion nanoparticles (UCNPs) have attracted an increasing amount of research interests, and have shown great potential for enhancing the practical utility of gene therapy, whose versatility has been limited by existing gene delivery technologies that are basically mono-functional in nature. Despite this, up to now in-depth analysis of the development of UCNPs for gene delivery has been scant in the literature, even though there has been an upsurge of reviews on the chemistry of UCNPs and their applications in bioimaging and drug delivery. To fill this gap, this review aims to present the latest advances in the development and applications of UCNPs as gene carriers. Prior to describing the prominent works published in the field, a critical view on the properties, chemistry and molecular design of UCNPs for gene delivery is provided. With a synopsis of the recent advances in UCNP-mediated gene delivery, challenges and opportunities could be illuminated for clinical translation of works in this nascent field of research.
Introduction
Current research in gene delivery has reached a bottle-neck in terms of efficiency and versatility. Hopes to change this situation may now be brought about by the emergence of photobiology, which not only enables imaging during gene therapy but also makes the precise control of the timing and location of the release of the loaded gene possible. To achieve this goal, over the years, different optically-active materials have been developed, ranging from quantum dots (QDs) to luminescent transition metal complexes. Each of them has their own merits and drawbacks in applications (Table 1) .
1-10 Among them, upconversion nanoparticles (UCNPs) have attracted extensive research interests and represent a hot topic in materials chemistry. Compared to the conventional down-conversion uorophores, UCNPs have several optical properties favourable for biomedical use, including negligible photobleaching and photoblinking, lower interference from auto-uorescence from surrounding tissues, higher spatial resolution, and less photodamage caused by the excitation light to fragile biological molecules.
Since the turn of the last century, the focus of research on UCNPs has been shied from the controlled synthesis of uniform nanoparticles to exploration of biomedical applications. [11] [12] [13] [14] In recent years, the potential of UCNPs has begun to receive considerable attention as a new approach to enhance the versatility of gene therapy. Unfortunately, up to now discussions on the emerging yet encouraging potential of UCNPs in gene delivery have been scant in the literature. This leaves a strong demand for a review lling this gap. The objective of this article is to meet this need by reviewing the latest development of UCNPs as gene carriers. It is hoped that by offering an outlook of current advances in this burgeoning area of research, further development can be facilitated by avoiding potential duplicate efforts, by enabling the identica-tion of challenges to be met, and by pointing to clearer directions for clinical translation of works on UCNP-based gene delivery in the future.
Overview of the properties of UCNPs
Rare earth elements consist of yttrium, scandium and the een elements in the lanthanide series. Except lanthanum and lutetium, the ions of all other lanthanides exhibit distinctive luminescence properties due to possible intra-4f or 4f-5d transitions led by the unique energy structures resulting from the 4f n inner shell conguration. 15, 16 Contrary to conventional uorophores that show downconversion caused by internal energy loss, UCNPs emit higher-energy outcome photons through sequential absorption of lower-energy incident ones.
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This process is called upconversion, which can be mediated using the long-lived and real ladder-like energy levels of lanthanide ions embedded in an inorganic matrix host.
Upconversion is a non-linear anti-Stokes process that is achieved mainly by three major mechanisms: excited-state absorption (ESA), energy transfer upconversion (ETU), and photon avalanche (PA). PA is rarely found in lanthanide materials at the nanoscale. Its importance to UCNP-based gene carriers, therefore, is less signicant. On the other hand, ETU is one of the commonly adopted mechanisms to achieve high upconversion efficiency in practice. During the process, a pump photon of the same energy is absorbed by each of the two neighbouring ions. The subsequent non-radiative energy transfer causes one of the ions to get excited to the upper energy level whereas the other one relaxes back to the ground state. The emission of photons with higher energy results from the relaxation of the excited ion. ETU can be achieved in a number of ways ( Fig. 1 ), including energy transfer followed by excitedstate absorption, successive energy transfer, cross-relaxation upconversion, cooperative sensitization and cooperative luminescence. As the mechanisms of luminescence emission from UCNPs have been reviewed elsewhere, readers are referred to those reviews for details.
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UCNPs generally consist of two parts: (i) trivalent lanthanide dopant ions and (ii) the inorganic host lattice that accommodates those ions. To enhance the upconversion emission, the host lattice has to be carefully selected. This involves consideration of several criteria. 22 For instance, the photon vibration energies shall be low. High chemical stability and close lattice matches to dopant ions are also required. Taking these criteria into account, uorides (e.g., NaYF 4 ) and oxides (e.g., Y 2 O 3 , La 2 O 3 and Lu 2 O 3 ) are some of the materials favourable to be used as host lattices for UCNP fabrication. [23] [24] [25] [26] [27] Apart from the selection of the host lattice, the choice of the dopant ions matters. In general, two types of dopant ions are required. One is the activator which emits visible light; whereas the other one functions as a sensitizer that donates energy. Some host-dopant systems commonly adopted for UCNP synthesis are listed in Table  2 . 23, 25, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] To improve the upconversion luminescence (UCL) efficiency of UCNPs, conventionally it is thought that the concentration of the sensitizer should be higher (approximately 20 mol%) than that of the activator, whose concentration has oen been controlled to be below 2 mol% to reduce luminescence quenching. 16 The validity of this conventional wisdom has recently been challenged by Johnson et al., 39 who have discovered that even if the Er 3+ concentration in NaY(Er)F 4 / NaLuF 4 core-shell nanocrystals is as high as 100 mol%, the emission intensity of both upconversion and downshied luminescence can still be enhanced, with no signicant concentration quenching effects being observed. This suggests that surface quenching rather than cross-relaxation between dopant ions may play a predominate role in causing luminescence quenching at high dopant concentrations. 39 This nding has revealed the possibility of constructing and engineering UCNPs in a way that is no longer restrained by the conventional limit of the activator concentration.
UCNPs are indeed only one of the many luminescent nanoparticles investigated in photobiology. Other nanoparticles widely studied for biomedical applications include transition metal complexes, QDs and organic uorophores. 48 the effect of UCNPs on cell behaviour is generally thought to be minimal. In spite of this, it is worth emphasizing that UCNPs are not necessarily toxicityfree. A previous study has reported that ligand-free lanthanide-doped nanoparticles can induce intracellular ATP deprivation in HeLa cells and can result in a signicant decrease in cell viability. 49 Such UCNP-induced cell death is attributed to the interactions of the nanoparticles with the phosphate group of cellular ATP to cause apoptosis and autophagy. 49 Nevertheless, UCNPs have a comparatively high safety prole among commonly used luminescent nanoparticles.
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Along with the ease of modulating their physicochemical properties via surface engineering, UCNPs turn out to be favourable building blocks for further development as multifunctional gene carriers.
Molecular design of UCNPs as gene carriers
A fundamental aspect of designing UCNP-based gene carriers is to determine the nanoparticle composition. When UCNPs are designed, dopant ions are oen chosen by considering not only the spaced energy levels that govern photon absorption by the sensitizer, but also the energy transfer process between the sensitizer and the activator. Yb 3+ has been widely adopted as a sensitizer, owing to its high absorption coefficient and upconversion efficiency. 50 In addition, the f-f transitions of many commonly used upconverting lanthanide ions (e. Apart from the nanoparticle composition, some other factors have to be considered so as to render the UCNPs applicable to gene delivery. For example, the nanoparticles should be biodegradable, biocompatible and non-toxic. [54] [55] [56] [57] In addition, gene delivery mediated by UCNPs is a multi-stage process (Fig. 2) . Contrary to the delivery of chemical drugs, in which the intervention will still be therapeutic even if the carrier fails to be internalized into cells but simply releases the payload outside, gene therapy is possible only when cellular internalization of the delivered gene is successful. [58] [59] [60] As far as cellular uptake is concerned, the size and zeta potential of the nanoparticles are two important determining factors. A small size can be achieved by surface passivation or functionalization to enhance the colloidal stability of UCNPs. 16, 61 This is pivotal when the nanoparticles are to be used in vivo, in which salt ions in blood may 72, 73 ) to the nanoparticle surface for receptor-mediated endocytosis. The feasibility of this has been evidenced by an earlier study, in which folic acid and anti-Her2 antibody have been conjugated to silica-coated NaYF 4 :Yb,Er UCNPs.
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Compared to the unmodied counterparts, ligand-conjugated UCNPs exhibit higher transfection efficiency and gene silencing efficiency in SK-BR-3 cells, in which Her2 receptors are overexpressed.
As UCNPs are mostly internalized via endocytosis, their ability to undergo endo-lysosomal escape (e.g., by eliciting the proton sponge effect) may determine the ultimate success of the gene delivery process. In order for the delivery process to be therapeutic, plasmids also have to reach the nucleus whereas RNA molecules have to be released in the cytosol. 59 For the former, one strategy to facilitate the nuclear import of the delivered nucleic material is to incorporate the UCNP surface with nuclear localization signal (NLS) peptides (e.g., PARP, M9-ScT conjugate, SV40 T antigen, Xenopus N1, adenovirus E1a, human c-myc, SV40 Vp3, and mouse FGF3), [75] [76] [77] [78] which can localize the nanoparticles to the nucleus and allow them to be actively transported across the nuclear pore complex. But even with proper intracellular localization, careful manipulation of the UCNPs, in particular the surface properties and the buffering capacity of the polymer coating, is required because this may inuence the process of gene release. Failure to dissociate the payload from the nanoparticles at the right location can indeed inuence the outcome deleteriously.
Fabrication of UCNP-based gene carriers
UCNP-based gene carriers can be constructed using various strategies. Co-precipitation is one of the simplest methods to generate UCNPs because it does not involve time-consuming procedures or severe reaction conditions. 79 By adding capping ligands into the solvent during the synthetic process, the growth of the nanoparticles can be controlled and the UCNPs can be stabilized. Examples of these capping ligands include polyvinylpyrrolidone (PVP), ethylenediaminetetraacetic acid (EDTA) and PEI. 37, 80, 81 In the case of NaYF 4 :Yb,Er nanocrystals, the upconversion emission exhibited by those in the hexagonal phase is generally higher than that exhibited by the cubic-phase counterparts. 82 However, nanocrystals synthesized via coprecipitation are oen in the cubic phase, and hence are not the most efficient upconverter. 83 To address this problem, calcinations at a high temperature can be applied to achieve the sharpened crystal structure or to mediate partial phase transfer to the hexagonal-phase nanocrystals. 37 Apart from NaYF 4 :Yb,Er nanocrystals, other nanoparticles (e.g., LuPO 4 :Yb,Tm and YbPO 4 :Er,Tm) have been successfully generated by coprecipitation, with subsequent heat treatment being applied to improve the upconversion efficiency. 84 Despite the wide application of co-precipitation in UCNP generation, particle aggregation may occur during the synthetic process, making precise control of the particle size difficult. As the size of the nanoparticles is an important parameter governing the efficiency of cellular internalization during the gene delivery process, the polydispersity of the generated nanocrystals is an issue to be tackled when the performance of a gene carrier is to be enhanced.
Another method of UCNP generation is thermal decomposition, in which solvents with a high boiling point (e.g., octadecene, oleic acid and oleylamine) are oen used to dissolve rare earth triuoroacetate precursors, which are oen thermolyzed at 300 C or above. 85, 86 Using this method, LiYF 4 and KGdF 4 UCNPs have been obtained. 87 Monodispersed hexagonalphase NaYF 4 :Yb,Er and NaYF 4 :Yb,Tm nanoparticles with enhanced upconversion emission have been generated, too.
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Notwithstanding this, due to the involvement of the use of expensive and air-sensitive metal precursors, 82 as well as the production of toxic by-products during the fabrication process, 85,88 the selection of this technique is not preferred sometimes. As an alternative to thermal decomposition, UCNPs can be synthesized via the sol-gel method, in which the metal precursors used are relatively cheap. This method has had a track record of applications in the fabrication of TiO 2 :Er, ZrO 2 :Er, Lu 3 Ga 5 O 12 :Er, YVO 4 :Yb,Er, and BaTiO 3 :Er UCNPs.
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Unfortunately, particle aggregation may occur when the nanoparticles generated by this method are dispersed in aqueous solutions. This limits the use of the nanoparticles in gene delivery, in which water is always the major medium through which gene carriers are delivered to target cells. Along with the occurrence of particle aggregation further induced by hightemperature calcinations, which is required to increase the crystalline phase purity so as to enhance luminescence emission, the sol-gel approach might not be the most suitable method for generation of UCNP-based gene vectors.
Apart from those mentioned above, UCNPs can be generated by the combustion method 94, 95 or by the hydro(solvo)thermal process. [96] [97] [98] Contrary to the former in which proper control of the particle size is challenging and the crystalline phase purity is generally low, the latter can generate high-quality UCNPs upon proper control of the process parameters (e.g., pH, reaction time, reaction temperature, and the type of precursors).
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In an earlier study, a-and b-phase NaYF 4 :Yb,Er UCNPs with well-controlled size and morphology have been generated using the hydrothermal method, with EDTA and citrate being used as the capping ligands. 99 The size of the particles has been shown to be controllable by manipulating the nucleation rate, which, in turn, can be adjusted by modulating the reactant concentration or by changing the type of ligands adopted. 99 In addition, by modifying the reaction time as well as the reactant concentration, phase transformation for the nanoparticles can be achieved. 99 This phenomenon can be exploited to control the morphology of the generated UCNPs. Lately, polymer-coated UCNPs with high aqueous solubility have been generated based on the hydro(solvo)thermal mechanism. 100 The high hydrophilicity has rendered the UCNPs favourable to be utilized in biological applications. Due to the ease of control of the properties (e.g., size, structure, and morphology) of the generated nanoparticles, along with the possibility of synthesizing the nanoparticles in a "one-pot" process, 81, 92, 101 the hydro(solvo)thermal method is and will continue to be one of the most favourable and convenient synthetic routes, in the practical sense, to UCNP-based gene carriers.
Surface modification of UCNPs for gene delivery
Surface modication can be adopted to optimize the biological performance of UCNP-based gene carriers (Fig. 3) . The roles played by surface modication can be two-fold. One is to improve the gene loading efficiency, and the other is to optimize the physicochemical properties of the nanoparticles for better biological performance. Each of these roles will be discussed in more detail in this section.
Enhancement of the gene loading process
Upon fabrication of the nanoparticles, usually surface modi-cation with cationic moieties will be exercised to render the nanoparticles applicable to gene loading. Polyelectrolyte complexation between nucleic acids and the cationic moieties on the nanoparticle surface is hitherto the most fundamental gene loading mechanism. In an earlier study, the surface of silica-coated NaYF 4 :Yb,Er UCNPs has been modied with amine groups using N- [3-(trimethoxysilyl) propyl]ethylenediamine (AEAPTMS), and as shown by the gel retardation assay, the modied UCNPs can complex with RNA molecules via electrostatic interactions between the positively charged amine groups and the negatively charged nucleic acid material.
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Surface modication of UCNPs can also be achieved by direct incorporation with polycations. One representative polycation used in this aspect is PEI, which is a cationic aziridine polymer with high proton buffering capacity over a wide range of pH values.
57,102 PEI has been extensively adopted for non-viral delivery of nucleic materials (including plasmids, 103 oligonucleotides 104 and ribozymes
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) in reagent-consuming animal studies. Its transfection efficiency can be optimized by modulating the physical-chemical features (e.g., charge density, degree of branching, and molecular weight) of the PEI molecules, [106] [107] [108] and by optimizing the transfection conditions (e.g., polyplex concentration and incubation time) 109 and polyplex properties (e.g., zeta potential and particle size). 109 In a previous study, gadolinium (Gd 3+ )-doped UCNPs have been modied rst by covalently conjugating PEG onto the nanoparticle surface, followed by deposition of PEI coatings using the layerby-layer assembly technique. 110 The PEI-coated UCNPs have not only been shown to be more effective in transfection than the uncoated counterparts, 110 but have also been reported to exhibit high gene delivery efficiency in the serum-containing environment, in which native PEI has experienced a signicant drop in the efficiency of transfection. 110 The nanoparticles have shown potential to be further developed into a gene carrier for biological use, in particular when parental administration of the therapeutic gene is required. Apart from PEI, other polycations have been adopted in the literature to coat UCNPs for enhancing the process of gene loading. For instance, PEGpoly(lactic-co-glycolic acid) (PEG-PLGA), along with a positively charged amphiphilic polymer synthesized by aminolyzing polysuccinimide (PSI) with N-(3-aminopropyl)imidazole (NAPI) and oleylamine, has been utilized to coat hydrophobic NaYF 4 :Yb,Er UCNPs. 111 Owing to the presence of the cationic coating, genes can effectively adsorb onto the UCNP surface, 111 rendering the nanoparticles applicable as gene vehicles.
Optimization of physicochemical properties
Not only effective drug loading but also high aqueous solubility is vital to the proper functioning of UCNPs when the nanoparticles are used as gene carriers. Yet a majority of lanthanidedoped UCNPs are poorly soluble in the aqueous environment. In recent years, several surface functionalization strategies have been put forward to increase the hydrophilicity of UCNPs. 16 One method is surface silanization, 112 whose applications in surface modication have been rapidly growing due to the availability of well-established routes to silica-coated nanoparticles and the applicability of silica-coating to both hydrophobic and hydrophilic surfaces. 113, 114 The feasibility of applying surface silanization to surface engineering of UCNPs has been demonstrated in a previous study, in which the affinity of PVP with silica has been exploited to coat PVP-stabilized NaYF 4 :Yb,Er nanocrystals with a uniform silica shell having a thickness of approximately 9 mm.
115 A similar approach has been used by Li and Zhang.
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They have produced water-soluble silica-coated PVP-stabilized NaYF 4 :Yb,Er nanocrystals whose shell thickness can be tuned by changing the concentration of tetraethoxysilane (TEOS), which is a precursor during the process of silica formation. All of these have evidenced the practicality of silica-coating in surface modication of UCNPs. Lately, Wang and co-workers have reported the fabrication of uorescent silica-coated mesoporous microcarriers. 116 The microcarriers show extended residence time of up to 3 days in the gastrointestinal tract, releasing more than 60% of their content. They can also emit in the near-infrared window of 1000-1400 nm, 116 thereby enabling real-time tracking of the microcarrier fate as well as allowing for semi-quantitative monitoring of the content of drug release in vivo. 116 Although at the moment the nanocarriers have been evaluated only for drug delivery, this study has offered insights into possible strategies for monitoring the kinetics and dynamics of a delivered agent aer administration to a living body. Along with the good biocompatibility of silicon, surface silanization may turn out to be promising for engineering the surface properties of UCNP-based gene carriers for theranostic applications in the future.
Other than surface silanization, surface engineering of UCNPs can be performed using non-silane reagents via diverse mechanisms, such as layer-by-layer assembly, 34 
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during which the carboxyl groups of PAA have been linked covalently with amino-modied PEG. Via the process of ligand exchange, an earlier study has also replaced the oleylamine ligands, which have been used to stabilize NaYF 4 :Yb,Er nanoparticles, with bifunctional organic molecules to render the nanoparticle surface hydrophilic. 88 More recently, based on the phenomenon that PEI and PAA exhibit higher binding affinity than PVP towards lanthanide ions, PEI-and PAA-coated NaYF 4 :Yb,Er UCNPs have been generated from PVP-stabilized nanoparticles. 121 The UCNPs show good dispersibility in aqueous media aer the ligand exchange process. 121 More details of different surface modication strategies to enhance the aqueous solubility of UCNPs are presented in Table 3 .
Surface modication can not only improve the particle hydrophilicity but can also modulate the physiochemical properties of UCNPs, thereby enhancing the efficiency of gene delivery. This has been revealed by multiphoton confocal microscopy and inductively coupled plasma mass spectrometry (ICP-MS) measurements, in which the PEI-coated UCNPs have been found to display greater efficiency in cellular internalization as compared to their counterparts having neutral or negative surface charges. 121 In addition to PEI, PEG is another polymer widely used as a surface modier due to its capacity of enhancing the aqueous solubility of various nanoparticulate gene delivery systems 122 and of reducing particle aggregation.
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Attributed to the hydrophilic nature of PEG and the brush-type polymer crowding, 124 PEGylated particles are usually less prone to opsonization and reticuloendothelial system (RES) uptake, and hence having the blood circulation time lengthened.
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Despite this, every coin has two sides. As hinted at by an earlier study, polyplexes that have undergone PEGylation display premature vector unpackaging in blood, causing a decline in the gene delivery efficiency to the liver. 126 Similar problems have been delineated by Mishra et al., 127 who have found that the cellular uptake and intracellular trafficking of polyplexes are impeded aer PEGylation, even though the salt stability of the polyplexes is enhanced. Taking all these into account, to maximize the positive effect of PEGylation in the molecular design of UCNP-based gene carriers, structural properties (e.g., density, conformation, molecular weight, and exibility) of the PEG moiety and the degree of PEG graing have to be carefully considered before PEGylation is executed. In addition, acidlabile linkages (e.g., vinyl ether, 128 acetals, 129, 130 and hydrazones
131
) can be used to link the PEG shield to the UCNP surface. The linkage can then be hydrolyzed in the acidic milieu of the endosomal compartment, leading to shielding destabilization and therefore mitigating the possible drawback of PEGylation to endolysosomal escape. 132 
Recent advances in UCNP-based gene transfer
With advances in the molecular design of UCNPs and the continuous development of technologies for materials fabrication, over the years copious UCNP-based carriers have been developed for delivery of nucleic acid materials. Based on the nature of the materials to be delivered, these carriers can be categorized into two types. One is for DNA delivery, and the other is for RNA delivery.
UCNP-based DNA delivery
As far as UCNP-based gene transfer is concerned, most of the efforts in the literature have been devoted to DNA delivery, whose practical potential in biomedicine has been evidenced in a pre-clinical trial, in which aminosilane-modied NaYF 4 :Yb,Er UCNPs have been exploited as carriers for DNA vaccination to combat foot-and-mouth disease (FMD). 133 The UCNPs can complex with the plasmid pcDNA3.1/VP1-GFP via electrostatic interactions, and protect the plasmid from DNase I degradation. 133 As revealed by in vitro studies, the transfection efficiency of the nanoparticles is comparable to lipofectamine, but with lower cytotoxicity. 133 Upon intramuscular injection of the UCNP/ DNA complex to guinea pigs, induction of the humoral and cellular immune responses has been achieved. 133 The serum levels of anti-FMDV specic antibodies and neutralizing antibodies, as well as the proliferation of T-lymphocytes, have also been found to be enhanced. 133 As conrmed by the challenge test, the guinea pigs vaccinated with the UCNP/DNA complex have been fully protected from attack by the FMD virus. 133 This study has pointed to the possible use of UCNP-based gene carriers in preventive medicine. Despite this, the unique optical properties of UCNPs have not been exploited during the design of the DNA vaccine carrier. Making use of those properties in the delivery system for additional capacity (e.g., photo-triggered release of the delivered plasmid during the vaccination process) can be the next rewarding step to pursue to escalate the application potential of the carrier in the clinical context. In fact, UCNPs can play at least two roles when they are incorporated into the design of a gene delivery system: (1) imaging-monitored gene delivery and therapy, and (2) temporal-spatial connement of gene manipulation. Each of them will be discussed individually below.
6.1.1 Imaging-monitored gene delivery and therapy. One immediate advantage brought about by using UCNPs as gene carriers is the possibility to track the delivery process via luminescence-based imaging. Over the years, advances in luminescence-based imaging have substantially facilitated the unravelling of the mechanisms of disease progression 134 and guiding the development of treatment for diseases such as choroidal melanomas, whose microcirculation has been successfully imaged in vivo using an indocyanine green (ICG) uorescent probe. 135 In UCNP-based gene delivery, the viability of integrating therapeutic and imaging functionalities into one single system has been shown by Bai et al., 111 who have coated hydrophobic NaYF 4 :Yb,Er UCNPs with PEG-PLGA and a positively charged PSI-based amphiphilic polymer. 111 Before the polymer coating process, the nanoparticles display high crystallinity with an average diameter of around 25 nm. Although there is an increase in the particle size aer the coating process, the average size is still in the size range favourable for cellular internalization. Importantly, the coated nanoparticles exhibit good biocompatibility and reasonable gene delivery efficiency. 111 Photoluminescence measurements have indicated that the coated nanoparticles show emission bands at around 540 nm and 660 nm. 111 These two bands are assigned to 4 111 This has rendered the UCNPs reported in the study applicable to imaging-guided therapy in the future.
Apart from luminescence-based imaging, UCNP-based gene carriers can be designed to mediate multimodal imaging. One example is provided by the case of PEI-coated NaGdF 4 :Yb,Er UCNPs, which can not only deliver plasmids in vitro but can also serve as a contrast agent for UCL, magnetic resonance imaging (MRI) and computed tomography (CT) (Fig. 4) . 136 Another example is given by He et al., 110 who have modied the surface of Gd 3+ -doped UCNPs with PEG and PEI for transfection.
Results have conrmed that the nanoparticles can not only function as gene carriers, but also display emission peaks at around 540 and 660 nm. 110 Even though the intensity of luminescence emission drops to 80% when 2 layers of PEI are incorporated into the nanoparticle surface, the intensity of the emission is sufficient for luminescence-based imaging (Fig. 5) . 110 Furthermore, as the nanoparticles are doped with Gd 3+ , they can provide contrast in MRI. Compared to gadolinium-diethylenetriamine penta-acetic acid (Gd-DTPA), the nanoparticles with 2 layers of PEI have been found to have a much higher longitudinal relaxivity value. 110 Considering their versatile imaging capacity and transfection activity, upon further development and optimization, the nanoparticles have high potential to serve as a multifunctional carrier for future theranostic applications.
Despite the promising advances made in the eld, owing to the low extinction coefficient and narrow band absorption of lanthanide ions, 137 the light absorbing ability of UCNPs is generally limited. This restrains the wide application of many of the reported UCNP-based gene carriers in imaging procedures. This situation is worsened by the fact that those carriers are in the nano-size range. The surface-to-volume ratio is, therefore, very high. This makes the emission efficiency of those carriers highly sensitive to surface-related deactivations. These deactivations can not only occur via direct deactivations, by neighbouring quenching centres, of the photoexcited dopants located on or around the UCNP surface, but can also happen if the energy possessed by the photoexcited dopants located in the centre of the nanoparticle randomly migrates to the dopants on or around the carrier surface or directly to the surface quenching sites. To solve this problem, one strategy is to take advantage of the antenna effect from other species with strong light-absorbing ability (e.g., plasmons, QDs or organic dyes) to compensate for the low extinction coefficient resulting from 4f-4f optical transitions in lanthanide ions. Another strategy is to suppress the surface-related quenching mechanisms by incorporating the UCNPs with a core-shell structure, in which the host material of the shell shows a low lattice mismatch with the core material. To fabricate UCNPs with the core-shell architecture, shell layers are usually deposited onto core nanocrystals via epitaxy. Epitaxial shells can be grown through chemical reactions similar to those adopted to generate the core particles, except that the process of crystal growth occurs on the core surface rather than in the liquid phase. To achieve epitaxial shell coating, one method is to use the heat-up strategy, which allows for the generation of UCNPs with a multi-shelled structure by either repeating the same synthetic protocol multiple times, or by arbitrarily combining dissimilar synthetic approaches for deposition of shells with different properties onto the same core crystal. 138 The viability of this strategy to enhance photoluminescence has been demonstrated by Zhang et al., 139 who have heated NaYF 4 :Yb,Er nanocrystals in an oleic acid/1-octadecene solution containing precursors for the formation of the hexagonal NaGdF 4 shell. Another strategy for epitaxial growth is the hot-injection method, in which a sequence of shell precursors is injected into a host reaction for the one-pot synthesis of multi-shelled nanoparticles. 117 The use of this method was rst reported in the early 2000's when NaYF 4 :-Yb,Er@NaYF 4 core-shell UCNPs were synthesized by rst heating related rare earth triuoroacetates in oleylamine for the growth of the NaYF 4 :Yb,Er core nanoparticles, followed by the injection of an oleylamine solution containing the shell precursors to achieve epitaxial deposition of the undoped NaYF 4 shell layer.
117 Using a similar approach, the synthesis of few other core-shell UCNPs (e.g., NaGdF 4 @NaGdF 4 and LiLuF 4 @LiLuF4) has been reported in the literature.
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Apart from the aforementioned methods of epitaxial growth, deposition of the shell layer can be exercised in a non-epitaxial manner, in which the shell layer can be immobilized on the surface of pre-synthesized UCNPs either by means of chemical bonding or through surface polymerization. 143, 144 Such methods have been employed for fabricating silica-coated NaYF 4 :Yb,Er UCNPs 144 and NaYF 4 :Yb,Tm UCNPs with tuneable surface coverage of gold nanoparticles. 145 With the incorporation of the multi-shelled nanostructure, the emission efficiency of UCNPs has been shown to be enhanced in several reports. For instance, aer coating with an undoped NaYF 4 shell, UCL emission from NaYF 4 :Yb,Er and NaYF 4 :Yb,Tm UCNPs has been found to be remarkably enhanced.
117 NaYF 4 :Yb,Er UCNPs with a hexagonal NaGdF 4 shell have also been reported to give more intense overall emission than the uncoated counterparts, owing to the passivation of surface defects of the nanocrystals by shell deposition. 139 All of these have evidenced the effectiveness of the core-shell nanostructure in enhancing the emission intensity of UCNPs and in strengthening the capacity of the nanoparticles to mediate imaging-monitored gene delivery and therapy in practice.
6.1.2 Temporal-spatial connement of gene manipulation. To achieve target-specic gene delivery, ligand conjugation to the carrier surface is a prevailing strategy; however, controlled release of nucleic acids may represent a new direction. The latter can be achieved using photoactivatable molecules that release payloads at specic sites upon UV irradiation. 146 The clinical application of this strategy has unfortunately been impeded by the toxicity and low tissue penetration power of UV light. This problem may be solved using UCNPs, which can convert near-infrared (NIR) or visible light to UV in situ to regulate the process of gene manipulation. The possible use of UCNPs to precisely control gene expression has recently been demonstrated in tumour cells that have been transplanted into adult zebrash.
147 Similar success has also been reported on silica-coated NaYF 4 :Yb,Tm nanocrystals, 148 in which the NIR-to-UV upconversion process has been exploited to silence the expression of target genes in a temporally and spatially specic manner. Such ability to manipulate gene expression has provided practical implications not only for treatment development but also for fundamental research on signal transduction. All of these are beyond the reach of conventional gene delivery methods.
As a matter of fact, while using UCNPs to control the location of gene manipulation is relatively new; similar concepts have already been used extensively in drug delivery research, in which UV light has been applied to manipulate the timing, dosage, and location of drug release. [149] [150] [151] [152] The process of phototriggered drug release is mediated by molecule excitation upon photon absorption and by the subsequent relaxation process, which is achieved via radiative and non-radiative pathways. In the radiative process, energy is usually emitted in the form of uorescence when the molecule in the excited state returns to the ground state; whereas in the non-radiative scenario, multiple pathways can be involved. One pathway is internal conversion, in which energy is released in the form of heat from an excited molecule. Another pathway is intersystem crossing, which involves the conversion of the singlet state of an excited molecule into a triplet state without emission of photons. In addition to these, excited molecules may undergo photochemical reactions (e.g., photocleavage, Wolff rearrangement, photoisomerization, and photocrosslinking) and experience nonradiative decay. Incorporation of these reactions into the molecular design of UCNP-based gene carriers is scant at the moment, but these reactions have already been well-adopted to control the delivery of chemical drugs. 146, 149, 153, 154 A good example has been given by Matyjaszewski and co-workers, who have synthesized a block copolymer having poly(ethylene oxide) (PEO) as the hydrophilic segment and poly(spiropyran methacrylate) as the hydrophobic part. 155 In an aqueous medium, the copolymer forms micelles with a core-shell structure. These micelles are disrupted upon UV irradiation, which causes the spiropyran unit to undergo a reversible isomerization between hydrophobic spiropyran (SP) and hydrophilic merocyanine (ME), leading to the release of the encapsulated agent. Upon irradiation with visible light, photochemical reversion from ME to SP occurs, and the disrupted micelles are reformed. More examples demonstrating the possible use of photochemical reactions in controlling payload release are provided in Table 4 . [156] [157] [158] [159] [160] [161] [162] In view of the similar nature between drug delivery and gene delivery, translating these strategies into the molecular design of UCNP-based gene carriers is not only theoretically feasible but may also enable more precise control of UCNPmediated gene manipulation in the future.
UCNP-based RNA delivery
If an UCNP-based gene carrier can load DNA via electrostatic interactions, the same carrier should be applicable to complex with RNA for delivery purposes, due to the similarity of the electrostatic properties between DNA and RNA molecules. Nevertheless, RNA shows extra vulnerability to enzymatic degradation, and proper protection of the RNA molecules during the delivery process is vital. An example of UCNPmediated RNA transfer is presented by an earlier study, in which UCNPs have been prepared by rst encapsulating Yb 3+ / Tm 3+ co-doped nanocrystals in a silica shell with surface amine groups, followed by surface functionalization with cationic photocaged linkers to make siRNA loading feasible (Fig. 6 ).
163
Upon NIR irradiation, the photocaged linker on the UCNP surface is cleaved by upconverted UV light. 163 This initiates the release of siRNA molecules in a temporal-spatial manner. A similar approach has been adopted by Guo et al., 148 who have used silica-coated NaYF 4 :Yb,Tm UCNPs as a carrier of siRNA to act against the expression of survivin. Those siRNA molecules have been caged with 4,5-dimethoxy-2-nitroacetophenone (DMNPE) before RNA delivery, and are subsequently uncaged by UV emitted from the UCNP-based carrier upon NIR irradiation. The success of RNAi mediated by the carrier has been veried using immunoblot analysis, which has revealed a signicant drop in survivin expression in murine bladder cancer cells (MB49 cell line). 148 With further optimization and characterization, the carrier may be further developed into a mediator of gene therapy in cancer treatment.
In addition to executing gene therapy alone, UCNP-based gene carriers may enable concomitant administration of multiple treatments. This has been exemplied by the positively charged polymer-coated NaGdF 4 :Yb,Er UCNPs, which have been reported for execution of both photodynamic therapy (PDT) and gene therapy. 164 Results have shown that the carrier can be loaded with the photosensitizer, namely chlorin e6 (Ce6), and with siRNA molecules that can silence Plk1 expression (Fig. 7) . 164 Upon excitation by NIR light at 980 nm, cancer cells are killed not only by cytotoxic singlet oxygen generated via resonance energy transfer from UCNPs to Ce6, but also by the anti-tumour activity of the siRNA molecules. 164 More recently, NaLuF 4 :Gd,Yb,Er UCNPs have been synthesized using carboxylcontaining glutarate as surface ligands, followed by conjugation with cypate, which is a carbocyanine uorophore with high photothermal conversion efficiency, through a hydrazide bond (Fig. 8A) . 165 Due to the magnetic and optical properties of the generated UCNPs, the nanoparticles function as a dualmodality contrast agent for UCL and MRI to guide oncotherapy (Fig. 8B) . Moreover, those UCNPs can effectively deliver siRNA molecules, which can act against heat shock protein 70, to cancer cells to enhance cell damage. 165 This damaging effect, along with photothermal ablation led by the conjugated cypate, has triggered signicant antitumor activity (Fig. 8C) . 165 Such 
UCNP-based gene delivery: limitations and possible solutions
Although, with the advances as presented above, the use of UCNPs as multifunctional gene carriers seems to be within reach, there are hurdles to overcome before clinical translation of innovations in the eld can be in full gear. These hurdles are mainly related to either emission efficiency or physiological performance. These challenges as well as possible solutions will be discussed here for future research.
Manipulation of emission properties
Regarding the role played by photoluminescence emission from UCNPs in gene delivery applications as discussed in the preceding sections, the emission efficiency signicantly determines the practicality of the nanoparticles in treatment. To date, the tunability of light emission has been attained by strategies such as controlling the dopant concentration, altering the host/activator combination, modulating the sizeand shape-induced surface effects, designing the core-shell structures, or utilizing appropriate energy transfer or migration pathways. At this moment, tuning upconversion emission from UCNPs is oen accompanied by a loss of the luminescence efficiency, 21 partly due to the deleterious cross relaxation events occurring between lanthanide ions. Yet, with an improvement in the efficiency of suppressing surface deactivations and in addressing different aspects of the colour tuning process, a new dimension brought to light emission tuning will be around the corner.
To induce luminescence emission from UCNPs, light at 980 nm is commonly used at the moment because this wavelength matches with the absorption of the commonly used sensitizer (Yb 3+ ). Light at this wavelength, however, can be absorbed by water, generating heat that may damage biological tissues. The capacity of exciting UCNPs at more tissuetransparent wavelengths is thus highly desired. 4 nanoparticles with the core-multishell architecture. Due to the absorption ltration effect of the NaGdF 4 :Yb,Tm layer, the nanoparticles can give power-density independent orthogonal excitation-emission UCL. Intriguingly, by changing the thickness of the ltration layer, the relative intensities of Er 3+ -dominated green emission and Tm 3+ -prominent blue emission can be tuned. These works, along with the emergence of Er 3+ -sensitized UCNPs which can be excited at multiple wavelengths for light emission, 39,170 have laid a foundation from which future efforts to manipulate the excitation wavelength of UCNPs to those transparent to tissues can be launched.
Optimization of the physiological performance
In addition to the limited luminescence efficiency, another challenge to be met is the poor biodegradability of UCNPs. Diagnostic agents injected into a human body, as required by the Food and Drug Administration (FDA), have to be completely eliminated in a reasonable timeframe.
171 This is to ensure that the area under the exposure curve can be minimized upon total body clearance. Unfortunately, UCNPs in general are not effective to be degraded and eliminated from the body. Earlier studies have reported that PAA-coated NaYF 4 :Yb,Er nanoparticles with an average diameter of 11.5 nm take 115 days for complete excretion, 172 whereas those with a diameter of around 30 nm fail to be completely excreted even 90 days aer in vivo administration. 173 To enhance excretion, the hydrodynamic size of UCNPs may need to be less than 10 nm.
21 Such hydrodynamic size, however, may not be the optimal diameter if gene transfer is involved. This is suggested by an earlier study in which PEI nanogels with mean diameters of 38, 75, 87, 121, 132 and 167 nm have been tested for transfection. 174 The highest efficiency has been shown to be achieved by particles that have mean diameters of 75 and 87 nm. This indicates that the optimal size for gene delivery may not coincide with the diameter of UCNPs that can be eliminated from the body most readily. The situation is more complicated when the UCNPs are used in preclinical and clinical studies, in which the size of the nanoparticles may affect the biodistribution pattern. In general, particles with a diameter smaller than 20-30 nm are more susceptible to renal excretion, 175, 176 whereas those having a larger diameter may tend to accumulate in the bone marrow, 177 heart, 178 stomach, 179 kidney, 175,176 spleen 180 and liver.
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Based on what has been presented above, the size of the UCNP-based gene carrier is preferred to be small for facilitating elimination from the body upon administration, but from the gene delivery point of view, the optimal size may be dened in a totally different way. Solving such a discrepancy will be an obstacle to be tackled for clinical translation of works on UCNPbased gene delivery. Apart from size optimization, right now a disproportionate amount of resources has been directed towards characterization of the properties of UCNP-based carriers simply as emissive materials. Evaluation of the biocompatibility of the carriers at the organ and body levels is lacking. To extend the use of the carriers from a laboratory context to clinical settings, additional efforts on evaluating the efficiency and long-term safety of the carriers will be the next stage to pursue.
Concluding remarks
Along with the advances in materials chemistry and fabrication, [182] [183] [184] [185] [186] [187] there has been a clear trend in gene transfer to move from simply delivering nucleic acid materials to, more recently, systems into which multiple functions have been incorporated. In virtue of their unique optical properties, since the turn of the last century UCNPs have started to make remarkable strides towards gene delivery applications. Although at present the most compelling illustrations of the functional richness of UCNPs as gene carriers are still conned to imaging and lightcontrolled gene manipulation, with the increasing maturation of fabrication technologies, many of the practical problems (including the poor biodegradability and the low quantum yield) in UCNPs will become solvable someday. The use of UCNPs in gene delivery will ultimately be limited only by the imagination of the scientist.
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